GHO Capital Partners-backed Envision Pharma Group completed the acquisition of Two Labs.

GHO Capital Partners-backed Envision Pharma Group, a global technology-enabled scientific communications company, completed the acquisition of Two Labs, a provider of integrated and customized commercial solutions to the pharmaceutical and biotechnology sector. Financial terms were not disclosed. "This exciting combination of Envision and Two Labs creates a compelling and unrivaled proposition in launch excellence partnership globally and in the US. We look forward to sharing our joint expertise and leveraging our complementary services across medical affairs and product launch planning to support our clients in their goal of bringing new medicines to market effectively and compliantly, to improve patient outcomes," David Thompson, Envision CEO.